K-Line Chart, actual market data is subject to the trading page.
Key Data
Prev. Open
$1.68
Prev. Close
$1.94
Prev. Day's Range
$1.67 - $1.97
52W Range
$1.44 - $16.00
Trading Volume
469.049K
MC
$52.557M
P/E Ratio
--
EPS
$-2.49
Company Overview
NASDAQ
Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology firm at the forefront of developing cutting-edge immunotherapy solutions for cancer treatment. The company’s flagship asset, Eli-002, utilizes a proprietary Amphiphilic TLR9 Agonist designed to generate strong immune responses against diverse cancer types, potentially improving patient outcomes significantly. Elicio's strategic focus on personalized cancer vaccines and innovative immunotherapeutic strategies places it in a unique position to address critical unmet needs in oncology, as it advances its promising pipeline through clinical trials aimed at reshaping cancer care.
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Headquarters451 D STREET, BOSTON, MA, UNITED STATES, 02210
ELTX operates in the [sector] sector and is focused on [core business description]. Its main activities involve [specific operations or products/services], which place it in the [specific industry] industry. The company aims to drive growth through [key strategies or focus areas].
ELTX's revenue is primarily driven by [specific products, services, or operations]. The company benefits from [specific market trends or demand factors] within the [sector or industry]. However, its profitability is subject to [mention any potential risks or market sensitivities].
ELTX's competitive advantages include [specific factors like technology, market position, or unique offerings]. These allow the company to differentiate itself from competitors in the [industry]. However, it also faces competition from [mention key competitors, if applicable], which could impact market share.
Investing in ELTX carries risks, including [specific risks like market volatility, regulatory concerns, or input cost changes]. Additionally, the company's performance is influenced by [economic, industry-specific, or company-specific factors]. Potential investors should consider these risks before making investment decisions.
As of now, ELTX does [not] pay dividends to shareholders. The company's dividend policy may reflect its focus on reinvesting earnings to support growth and operations. Investors should review its dividend history and future updates for additional insights.
ELTX is positioned as a [describe its competitive positioning, such as market leader, niche player, innovator] in the [industry]. It competes with companies like [key competitors]. The company's strategic focus on [highlight strategies or strengths] helps it navigate competitive pressures in the market.
ELTX has growth opportunities tied to [specific trends, market expansions, or innovations]. The company's focus on [specific strategic initiatives] and its position in the [industry] offer avenues for scaling and capturing market share. However, these opportunities depend on [mention key conditions or industry developments].
Valuation factors for ELTX include its [recent earnings, growth trajectory, price-to-earnings ratio, or other financial metrics]. Industry trends, competitive position, and its ability to manage [key financial or operational metrics] will also impact its long-term valuation. Investors should analyze its financial performance and market positioning before investing.
Risk Warning
1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
3.The information contained on this page is for reference only and does not constitute any investment advice.
Transfer
